Optherion's AMD Drug Nabs $37M Series A

October 2007
Bioworld Week;10/15/2007, Vol. 15 Issue 42, p3
The article reports that Optherion Inc. in Connecticut has raised $37 million in a Series A round to further preclinical research with a new approach for the diagnosis and treatment of age-related macular degeneration (AMD). Optherion focuses on genetic mutations in Complement Factor H, which occur in around 50% of AMD patients. The firm aims to develop a genetic test to identify patients with Complement Factor H mutations and treat them with a recombinant form of Complement Factor H protein.


Related Articles

  • Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis-β-carotene. Rotenstreich, Ygal // British Journal of Ophthalmology;May2010, Vol. 94 Issue 5, p616 

    BACKGROUND: Fundus albipunctatus is a retinal dystrophy caused by a mutation in the gene encoding 11-cis-retinol dehydrogenase which delays the recovery of rod photoreceptor cells from light stimulation leading to night blindness. A recent study of a mouse model of fundus albipunctatus treated...

  • 'Objective Assessment of Retinal Thickness Seems to Be a Valuable Tool in the Management of Diabetic Macular Edema' Sander, Birgit // Review of Ophthalmology;Oct2001 Part 2, Vol. 8 Issue 10, p7 

    Assesses the effectiveness of Retinal Thickness Analyzer in the management of diabetic macular edema. Comparison of retinal thickness between diabetic eyes with and without clinically significant macular edema; Reduction in retinal thickness after laser treatment; Correlation of retinal...

  • Diffüz Fotoreseptör Distrofileri. BAYAR, Sezin AKÇA; ŞINGAR, Evin; YILMAZ, Gürsel // Retina-Vitreus/Journal of Retina-Vitreous;2012, Vol. 20 Issue 4, p243 

    Cone rod dystrophies (CRDs) are retinal dystrophies caused by the loss of cone receptors (congenital loss or late-onset de-generation) or abnormalities of cone pigments. Mostly CRDs are non syndromic, but they can be part of several syndromes, such as the Bardet Biedl syndrome or Spinocerebellar...

  • Unexpected mutations put stem cell trial on hold. Coghlan, Andy // New Scientist;8/8/2015, Vol. 227 Issue 3033, p9 

    The article reports that a stem-cell trial using induced pluripotent stem cells has been halted after mutations were found in the cells of a participant, including a mutation that could carry a remote cancer risk, and mentions the trial turned skin cells into retinal cells to try and reverse...

  • Generation of a Uracil Auxotroph Strain of the Probiotic Yeast Saccharomyces boulardii as a Host for the Recombinant Protein Production. Hamedi, Hassan; Misaghi, Ali; Modarressi, Mohammad Hossein; Salehi, Taghi Zahraei; Khorasanizadeh, Dorsa; Khalaj, Vahid // Avicenna Journal of Medical Biotechnology;Jan-Mar2013, Vol. 5 Issue 1, p29 

    Background: Saccharomyces boulardii (S. boulardii) is the best known probiotic yeast. The genetic engineering of this probiotic strain requires the availability of appropriate mutants to accept various gene constructs carrying different selection markers. As the auxotrophy selection markers are...

  • Identification of genetic variants in PDC, RHO, PDE6A and PDE6B in dogs with progressive retinal atrophy. Pandya, Dipal Y.; Patel, Namrata V.; Shah, Tejas M.; Patel, Anand B.; Parmar, Nidhi R.; Reddy, Bhaskar; Joshi, Chaitanya G.; Kelawala, Divyesh N.; Patil, Deepak B. // Current Science (00113891);11/25/2016, Vol. 111 Issue 10, p1640 

    The progressive retinal atrophy (PRA) is an inherited eye disease and characterized by progressive retinal degeneration which leads to impaired vision in dogs. Using targeted next generation sequencing of nine PRA cases and six controls, we have identified SNPs in PDC, PDE6A and PDE6B, which...

  • A Naturally-Derived Compound Schisandrin B Enhanced Light Sensation in the pde6c Zebrafish Model of Retinal Degeneration. Zhang, Liyun; Xiang, Lue; Liu, Yiwen; Venkatraman, Prahatha; Chong, Leelyn; Cho, Jin; Bonilla, Sylvia; Jin, Zi-Bing; Pang, Chi Pui; Ko, Kam Ming; Ma, Ping; Zhang, Mingzhi; Leung, Yuk Fai // PLoS ONE;3/1/2016, Vol. 11 Issue 3, p1 

    Retinal degeneration is often progressive. This feature has provided a therapeutic window for intervention that may extend functional vision in patients. Even though this approach is feasible, few promising drug candidates are available. The scarcity of new drugs has motivated research to...

  • Deleting the 14-3-3 Protein Bmhl Extends Life Span in Saccharomyces cerevisiae by Increasing Stress Response. Chen Wang; Skinner, Craig; Easlon, Erin; Su-Ju Lin // Genetics;Dec2009, Vol. 183 Issue 4, p1373 

    Enhanced stress response has been suggested to promote longevity in many species. Calorie restriction (CR) and conserved nutrient-sensing target of rapamycin (TOR) and protein kinase A (PKA) pathways have also been suggested to extend life span by increasing stress response, which protects cells...

  • Which imaging platform is your 'go-to' tool for diagnosis and management of macular edema?  // Ocular Surgery News;11/25/2012, Vol. 30 Issue 22, Special section p4 

    The article provides answers related to the tool for diagnosis and management of macular edema.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics